Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: Systematic review and meta-analysis

BMC Pregnancy and Childbirth

Volumn 8, Issue , 2008, Pages

  Morris, Rachel K ^a   Cnossen, Jeltsje S ^a   Langejans, Marloes ^a   Robson, Stephen C ^a   Kleijnen, Jos ^a   ter Riet, Gerben ^a   Mol, Ben W ^a   Van der Post, Joris A M ^a   Khan, Khalid S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRADIOL; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A; BIOLOGICAL MARKER; ESTRIOL; INHIBIN;

ACCURACY; ARM CIRCUMFERENCE; BIRTH WEIGHT; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COCHRANE LIBRARY; DIASTOLIC BLOOD PRESSURE; DOWN SYNDROME; EMBASE; GESTATION PERIOD; HEAD CIRCUMFERENCE; HEALTH CARE DELIVERY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL CARE; MAXIMUM LIKELIHOOD METHOD; MEDICAL EXPERT; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; METHODOLOGY; PREDICTION; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PREVENTIVE MEDICINE; PROTEINURIA; QUALITY CONTROL; RELIABILITY; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SKINFOLD THICKNESS; SMALL FOR DATE INFANT; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD; FEMALE; GESTATIONAL AGE; MASS SCREENING; METABOLISM; PRENATAL CARE;

ALPHA-FETOPROTEINS; ASPIRIN; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; ESTRIOL; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INHIBINS; MASS SCREENING; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL CARE;

EID: 51649120342     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-8-33     Document Type: Review

References (154)

1. Hay WW JI Catz CS Grave GD Yaffe SJ Workshop summary: Fetal growth: its regulation and disorders Pediatrics 1997, 99(6):585-591 9093303
2. McIntire DJ Bloom SL Casey BM Levenko KJ Birth weight in relation to morbidity and mortality among newborn infants N Eng J Med 1999, 340(16):1234-1238 10.1056/NEJM199904223401603
3. Taylor DJ Howie PW Fetal growth achievement and neurodevelopmental disability Br J Obstet Gynaecol 1989, 96(7):789-794 2475158
4. Rich-Edwards J Colditz G Stampfer M Willett W Gillman M Hennekens C Birthweight and the risk for type 2 diabetes mellitus in adult women Ann Intern Med 1999, 130(4 Pt 1):278-284 10068385
5. Barker DJ The developmental origins of chromic adult disease Acta Paediatr Suppl 2004, 93(446):26-33 15702667
6. Wapner R Thom E Simpson JL Pergament E Silver R Filkins K First trimester screening for trisomies 21 and 18 N Eng J Med 2003, 349(15):1405-1413 10.1056/NEJMoa025273
7. Yaron Y Cherry M Kramer RL O'Brien JE Hallak M Johnson MP Evans MI Second-trimester maternal serum marker screening: Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome Am J Obstet Gynecol 1999, 181(4):968-974 10.1016/S0002-9378(99)70334-0 10521763
8. Aquilina J Maplethorpe R Ellis P Harrington K Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia Placenta 2000, 21(5-6)487-492 10.1053/ plac.2000.0540 10940198
9. Ong CY Liao AW Spencer K Munim S Nicolaides KH First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications BJOG 2000, 107(10):1265-1270 10.1111/j.1471-0528.2000.tb11618.x 11028579
10. Morssink LP Kornman LH Hallahan TW Kloosterman MD Beckhuis JR De Wolf BT Montingh A Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery Prenat Diagn 1998, 18(2):147-152 10.1002/(SICI)1097-0223(199802)18:2<147::AID-PD231>3.0.CO;2-W 9516016
11. Askie L Duley L Henderson-Smart D Stewart L Antiplatelet agents for preventing pre-eclampsia: A meta-analysis of individual patient data Lancet 2007, 369(9575):1791-1798 10.1016/S0140-6736(07)60712-0 17512048
12. Coomarasamy A Frisk NM Gee H Robson SC The Investigation and Management of the Small for Gestational Age Fetus Guideline No 31 Nov 2002 RCOG, London 2003
13. Cnossen JS Post van der JAM Mol BW Khan KS Meads C der Riet G Prediction of pre-eclampsia: A protocol for systematic reviews of test accuracy BMC Pregnancy and Childbirth 2006, 6:29 10.1186/1471-2393-6-29
14. Morris RK Khan K Coomarasamy A Robson S Kleijnen J The value of prediciting fetal growth restriction and compromise of its wellbeing: Systematic quantitative overviews (meta-analysis) of test accuracy literature BMC Pregnancy and Childbirth 2007, 7:3 10.1186/1471-2393-7-3
15. Cochrane Methods Working Group on Systematic Reviews of Screening and Diagnostic Tests Recommended methods 1996
16. Deeks J Systematic reviews in health care: Systematic reviews of diagnostic and screening tests BMJ 2001, 323(7305):157-162 1120791 11463691 10.1136/bmj.323.7305.157
17. Irwig L Tosteson AN Gatsonis C Low J Colditz G Chalmers TC Mosteller F Guidelines for meta-analyses evaluating diagnostic tests Ann Intern Med 1994, 120(8):667-676 8135452
18. Khan KS Dinnes J Kleijnen J Systematic reviews to evaluate diagnostic tests Eur J Obstet Gynecol Reprod Biol 2001, 95(1):6-11 10.1016/ S0301-2115(00)00463-2 11267714
19. Brown MA Lindheimer MD de Swiet M Van Assche A Moutquin JM The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 2001, 20(1):IX-XIV 10.1081/ PRG-100104165 12044323
20. McCowan LM Harding JE Stewart AW Customized birthweight centiles predict SGA pregnancies with perinatal morbidity BJOG 2005, 112(8):1026-1033 16045513
21. Owen P Farrell T Hardwick JC Khan KS Relationship between customised birthweight centiles and neonatal anthropometric features of growth restriction BJOG 2002, 109(6):658-662 10.1111/j.1471-0528.2002.01367.x 12118644
22. Fay RA Dey PL Saadie CM Buhl JA Gebski VJ Ponderal index: A better definition of the 'at risk' group with intrauterine growth problems than birth-weight for gestational age in term infants Aust N Z J Obstet Gynaecol 1991, 31(1):17-19 10.1111/j.1479-828X.1991.tb02755.x 1872765
23. Tamim H Beydoun H Itani M Khogali M Chokr I Yunis KA The National Collaborative Perinatal Neonatal Network Predicting neonatal outcomes: birthweight, body mass index or ponderal index? J Perinat Med 2004, 32(6):509-513 10.1515/JPM.2004.120 15576272
24. Excler J Sann L Lasne Y Picard J Anthropometric assessment of nutritional status in newborn infants. Discriminative value of mid arm circumference and of skinfold thickness Early Hum Dev 1985, 11(2):169-178 10.1016/0378-3782(85)90104-5 4029053
25. Whiting P Rutjes AW Reitsma JB Bossuyt PM Kleijnen J The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 2003, 3:25 305345 14606960 10.1186/1471-2288-3-25
26. Whiting PF Weswood ME Rutjes AW Reitsma JB Bossuyt PN Kleijnen J Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies BMC Med Res Methodol 2006, 6:9 1421422 16519814 10.1186/ 1471-2288-6-9
27. Bossuyt PM Reitsma JB Bruns DE Gatsonis CA Glasziou PP Orwig LM Lijmer JG Moher D Rennie D de Vet HC the STARD Group Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative BMJ 2003, 326(7379):41-44 1124931 12511463 10.1136/ bmj.326.7379.41
28. Lijmer JG Mol BW Heisterkamp S Bonsel GJ Prins MH Meulen van der JH Bossuyt PM Empirical evidence of design-related bias in studies of diagnostic tests JAMA 1999, 282(11):1061-1066 10.1001/jama.282.11.1061 10493205
29. Rutjes AW Reitsma J Di N Smidt N van Rijn J Bossuyt PM Evidence of bias and variation in diagnostic accuracy studies CMAJ 2006, 174(4):469-476 1373751 16477057
30. Whiting P Rutjes AW Dinnes J Reitsma J Bossuyt PM Kleijnen J Development and validation of methods for assessing the quality of diagnostic accuracy studies Health Technol Assess 2004, 8(25):iIi, 1-234 15193208
31. Honest H Khan KS Reporting of measures of accuracy in systematic reviews of diagnostic literature BMC Health Serv Resh 2002, 2(1):4 10.1186/ 1472-6963-2-4
32. Jaeschke R Guyatt GH Sackett DL Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group JAMA 1994, 271(9):703-707 10.1001/ jama.271.9.703 8309035
33. Khan K Chien PF Seizure prophylaxis in hypertensive pregnancies: A framework for making clinical decisions Br J Obstet Gynaecol 1997, 104(10):1173-1179 9332996
34. Gulmezoglu M de OM Villar J Effectiveness of interventions to prevent or treat impaired fetal growth Obstet Gynecol Surv 1997, 52(2):139-149 10.1097/00006254-199702000-00023 9027913
35. Florio P Reis FM Pezzani I Luisi S Severi FM Petraglia F The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia Ultrasound Obstet Gynecol 2003, 21(2):165-169 10.1002/uog.29 12601840
36. Zeeman GG Alexander JM McIntire DD Byrd W Leveno KJ Inhibin-A and superimposed preeclampsia in women with chronic hypertension Obstet Gynecol 2003, 101(2):232-236 10.1016/S0029-7844(02)02640-6 12576244
37. Yaron Y Ochshorn Y Heifetz S Lehavi O Sapir Y Orr-Urtreger A First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome Fetal Diagn Ther 2002, 17(6):352-356 10.1159/000065384 12393965
38. Yaron Y Heifetz S Ochshorn Y Lehavi O Orr-Urtreger A Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome Prenat Diagn 2002, 22(9):778-782 10.1002/pd.407 12224070
39. Smith GC Stenhouse EJ Crossley JA Aitken DA Cameron AD Connor JM Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth J Clin Endocrinol Metab 2002, 8(4)(7):1762-1767 10.1210/ jc.87.4.1762
40. Aquilina J Thompson O Thilaganathan B Harrington K Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler Ultrasound Obstet Gynecol 2001, 17(16):477-484 10.1046/j.1469-0705.2001.00382.x 11422967
41. Lee LC Sheu BC Shau WY Liu DM Lai TJ Lee YH Huang SC Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia Prenat Diagn 2000, 20(9):738-743 10.1002/1097-0223(200009)20:9<738::AID-PD917>3.0.CO;2-R 11015703
42. Leung TN Chung TK Madsen G Lam CWK Lam PKW Walters WAW Smith R Analysis of mid-trimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia Hum Reprod 2000, 15(8):1813-1818 10.1093/humrep/15.8.1813 10920109
43. Muttukrishna S North RA Morris J Schellenberg JC Taylor RS Asselin J Ledger W Groome N Redman CWG Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia Hum Reprod 2000, 15(7):1640-1645 10.1093/humrep/15.7.1640 10875882
44. Lambert-Messerlian GM Silver HM Petraglia F Luisi S Pelzani I Maybruck WM Hogge WA Hanley-Yanez K Roberts JM Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy J Soc Gynecol Investig 2000, 7(3):170-174 10.1016/S1071-5576(00)00050-2 10865185
45. Sebire NJ Roberts L Noble P Wallace E Nicolaides KH Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre-eclampsia BJOG 2000, 107(6):795-797 10.1111/ j.1471-0528.2000.tb13343.x 10847238
46. Stamilio DM Sehdev HM Morgan MA Propert K Macones GA Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol 2000, 182(3):589-594 10.1067/ mob.2000.103890 10739512
47. Haddad B Abirached F Louis-Sylvestre C Le Blond J Paniel BJ Zorn JR Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation Hum Reprod 1999, 14(11):2872-2875 10.1093/ humrep/14.11.2872 10548639
48. Raty R Koskinen P Alanen A Irjala K Matinlauri I Ekblad U Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels Prenat Diagn 1999, 19(2):122-127 10.1002/ (SICI)1097-0223(199902)19:2<122::AID-PD491>3.0.CO;2-R 10215068
49. Pouta AM Hartikainen AL Vuolteenaho OJ Ruokonen AO Laatikainen TJ Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia Obstet Gynecol 1998, 91(6):940-944 10.1016/S0029-7844(98)00112-4 9611000
50. Luckas M Hawe J Meekins J Neilson J Walkinshaw S Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia Acta Obstet Gynecol Scand 1998, 77(4):381-384 10.1034/ j.1600-0412.1998.770404.x 9598944
51. Onderoglu LS Kabukcu A Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome Int J Gynaecol Obstet 1997, 56(3):245-249 10.1016/S0020-7292(96)02830-5 9127156
52. Ashour AM Lieberman ES Haug LE Repke JT The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia Am J Obstet Gynecol 1997, 176(2):438-442 10.1016/S0002-9378(97)70512-X 9065195
53. Jauniaux E Gulbis B Tunkel S Ramsay B Campbell S Meuris S Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies Prenat Diagn 1996, 16(12):1129-1135 10.1002/ (SICI)1097-0223(199612)16:12<1129::AID-PD9>3.0.CO;2-I 8994249
54. Waller DK Lustig LS Cunningham GC Feuchtbaum LB Hook EB The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications Obstet Gynecol 1996, 88(5):816-822 10.1016/0029-7844(96)00310-9 8885920
55. Heinonen S Ryynanen M Kirkinen P Saarikoski S Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion Am J Perinatol 1996, 13(7):437-441 8960614
56. Muller F Savey L Le Fiblec B Bussieres L Ndayizamba G Colau JC Giraudet P Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia Am J Obstet Gynecol 1996, 175(1):37-40 10.1016/S0002-9378(96)70247-8 8694072
57. Wenstrom KD Owen J Davis RO Brumfield CG Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein Obstet Gynecol 1996, 87(2):213-216 10.1016/0029-7844(95)00377-0 8559526
58. Vaillant P David E Constant I Athmani B Devulder G Fievet P Gondry J Boulanger JC Fardelone P Fournier A Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation Nephron 1996, 72(4):557-563 8730421
59. Simpson JL Palomaki GE Mercer B Haddow JE Andersen R Sibai B Elias S Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements Am J Obstet Gynecol 1995, 173(6):1742-1748 10.1016/ 0002-9378(95)90420-4 8610755
60. Milunsky A Jick SS Bruell CL Maclaughlin DS Tsung YK Jick H Rothman KJ Willett W Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: New epidemiologic data Am J Obstet Gynecol 1989, 161(2):291-297 2475017
61. Capeless EL Kelleher PC Walters CP Elevated maternal serum alpha-fetoprotein levels and maternal risk factors: Their association with pregnancy complications J Reprod Med 1992, 37(3):257-260 1373447
62. Morssink LP Heringa MP Beekhuis JR De Wolf BT Mantingh A The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein Obstet Gynecol 1997, 89(5 Pt 1):666-670 10.1016/S0029-7844(97)00088-4 9166297
63. Roes EM Gaytant MA Thomas CM Raijmakers MTM Zusterzeel PLM Peters WHM Steegers EAP First trimester inhibin-A concentrations and later development of preeclampsia Acta Obstet Gynecol Scand 2004, 83(1):117 10.1111/j.1600-0412.2004.00140.x 14758802
64. Audibert F Benchimol Y Benattar C Champagne C Frydman R Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry Fetal Diagn Ther 2005, 20(1):48-53 10.1159/000081369 15608460
65. Brajenovic-Milic B Tislaric D Zuvic-Butorac M Back J Petrovic O Ristic S Mimica M Kapovic M Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes Fetal Diagn Ther 2004, 19(6):483-487 10.1159/000080159 15539871
66. Dugoff L Hobbins JC Malone FD Porter TF Luthy D Comstock CH Hankins G Berkowitz RL Merkatz I Craigo SD Timor-Tritsch IE Carr SR Wolfe HM Vidavar J D'Alton ME First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (the FASTER Trial) Am J Obstet Gynecol 2004, 191(4):1446-1451 10.1016/j.ajog.2004.06.052 15507981
67. Dugoff L Hobbins JC Malone FD Vidaver J Sullivan L Canick JA Lambert-Messerlian GM Porter TF Luthy DA Comstock CH Saade G Eddleman K Merkatz IR Craigo SD Timor-Tritsch IE Carr SR Wolfe HM D'Alton ME FASTER Trial Research Consortium Quad screen as a predictor of adverse pregnancy outcome Obstet Gynecol 2005, 106(2):260-267 16055573
68. Ay E Kavak ZN Elter K Gokaslan H Pekin T Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy Aust N Z J Obstet Gynaecol 2005, 45(4):283-288 10.1111/j.1479-828X.2005.00412.x 16029293
69. Hershkovitz R De SM Kingdom J Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler Hypertens Pregnancy 2005, 24(3):273-280 10.1080/ 10641950500280995 16263599
70. Roiz-Hernandez J de JC-M Fernandez-Mejia M Human chorionic gonadotropin levels between 16 and 21 weeks of pregnancy and prediction of pre-eclampsia Int J Gynaecol Obstet 2006, 92(2):101-105 10.1016/ j.ijgo.2005.10.002 16325185
71. Spencer K Yu CK Cowans NJ Otigbah C Nicolaides KH Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler Prenat Diagn 2005, 25(10):949-953 10.1002/pd.1251 16086443
72. Spencer K Yu CK Savvidou M Papageorghiou AT Nicolaides KH Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation Ultrasound Obstet Gynecol 2006, 27(6):559-564 10.1002/uog.2676
73. Wald NJ Morris JK Ibison J Wu T George LM Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers Prenat Diagn 2006, 26(6):559-564 10.1002/pd.1459 16700087
74. Pilalis A Souka AP Antsaklis P Daskalakis G Papantoniou N Mesogitis S Antsaklis A Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation Ultrasound Obstet Gynecol 2007, 29(2):135-140 10.1002/uog.3881 17221926
75. Kowalczyk TD Cabaniss ML Cusmano L Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome Obstet Gynecol 1998, 91(3):396-400 10.1016/S0029-7844(97)00677-7 9491867
76. Akinbiyi AA Unexplained elevated maternal serum alpha-fetoprotein in singleton pregnancies as a predictor of fetal risk Int J Gynaecol Obstet 1996, 53(1):17-21 10.1016/0020-7292(95)02633-9 8737299
77. Benn PA Horne D Briganti S Rodis JF Clive JM Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein Obstet Gynecol 1996, 87(2):217-222 10.1016/ 0029-7844(95)00390-8 8559527
78. Bernstein IM Barth RA Miller R Capeless EL Elevated maternal serum alpha-fetoprotein: Association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies Obstet Gynecol 1992, 79(1):71-74 1370124
79. Bewley S Chard T Grudzinskas G Cooper D Campbell S Early prediction of uteroplacental complications of pregnancy using Doppler ultrasound, placental function tests and combination testing Ultrasound Obstet Gynecol 1992, 2(5):333-337 10.1046/j.1469-0705.1992.02050333.x 12796932
80. Bloxam DL Williams NR Waskett RJ Stewart SG Disturbed zinc metabolism and reduced birthweight related to raised maternal serum alpha-fetoprotein in normal human pregnancies. [Review] [49 refs] Acta Obstet Gynecol Scand 1994, 73(10):758-764 10.3109/00016349409072500 7529457
81. Brazerol WF Grover S Donnenfeld AE Unexplained elevated maternal serum alpha-fetoprotein levels and perinatal outcome in an urban clinic population Am J Obstet Gynecol 1994, 171(4):1030-1035 7524321
82. Bremme K Eneroth P Nilsson B Marsk L Hagenfeldt L Outcome of pregnancy in relation to maternal serum alpha-fetoprotein levels in the second trimester. An evaluation of a screening program and a longitudinal follow-up Gynecol Obstet Invest 1988, 26(3):191-205 2467849
83. Brock DJ Barron L Raab GM The potential of mid-trimester maternal plasma alpha-fetoprotein measurement in predicting infants of low birth weight Br J Obstet Gynaecol 1980, 87(7):582-585 6158993
84. Buckland CM Thom H Campbell AG Maternal serum alpha-fetoprotein levels in low birth weight singleton pregnancies J Perinat Med 1984, 12(3):127-132 6209381
85. Burton BK Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein Obstetrics & Gynecology 1988, 72(5):709-713
86. Chapman SJ Brumfield CG Wenstrom KD Dubard MB Pregnancy outcomes following false-positive multiple marker screening tests Am J Perinatol 1997, 14(8):475-478 9376009
87. Chard T Rice A Kitau MJ Hird V Grudzinskas JG Nysenbaum AM Mid-trimester levels of alphafetoprotein in the screening of low birthweight Br J Obstet Gynaecol 1986, 93(1):36-38 2417618
88. Chitayat D Farrell SA Huang T Meier C Wyatt PR Summers AM Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes Am J Obstet Gynecol 2002, 187(3):758-763 10.1067/mob.2002.125240 12237660
89. Cho S Durfee KK Keel BA Parks LH Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening J Perinat Med 1997, 25(6):476-483 9494919
90. Cox MU Kingdom J Whittle M McNay M Fleming J Bowman A Crossley J Aitken D [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: Perinatal results] Rev Chil Obstet Ginecol 1995, 60(3):174-180 8728745
91. Cusick W Rodis JF Vintzileos AM Albini SM McMahon M Campbell WA Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation J Reprod Med 1996, 41(5):327-332 8725757
92. Di MM Piazzi G Ferrari A Lotzniker M Gerola O Spinillo A A simultaneous evaluation of second trimester serum AFP, hCG and unconjugated oestriol as predictors of small for gestational age births Italian Journal of Gynaecology & Obstetrics 1998, 10(4):155-159
93. Doran TA Valentine GH Wong PY Wielgosz G Benzie RJ Soltan HC Jenner MR Morland PA Montogomery RJ Allen LC Maternal serum alpha-fetoprotein screening: Report of a Canadian pilot project CMAJ 1987, 137(4):285-293 1494022 2440547
94. Dungan JS Shulman LP Phillips OP Simpson JL Meyer NL Grevengood C Elias S Positive serum screening for fetal Down syndrome does not predict adverse pregnancy outcome in absence of fetal aneuploidy J Soc Gynecol Investig 1994, 1(1):55-58 9419747
95. Duric K Skrablin S Lesin J Kalafatic D Kuvacic I Suchanek E Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy Eur J Obstet Gynecol Reprod Biol 2003, 110(1):12-15 10.1016/S0301-2115(03)00081-2 12932863
96. Endres LK Krotz S Grobman WA Isolated low second-trimester maternal serum beta-human chorionic gonadotropin is not associated with adverse pregnancy outcome Am J Obstet Gynecol 2003, 189(3):755-757 10.1067/ S0002-9378(03)00655-0 14526308
97. Evans J Stokes IM Outcome of pregnancies associated with raised serum and normal amniotic fluid alpha fetoprotein concentrations Br Med J (Clin Res Ed) 1984, 288(6429):1494 1441175 6202356
98. Ghosh A Tang MH Tai D Nie G Ma HK Justification of maternal serum alphafetoprotein screening in a population with low incidence of neural tube defects Prenat Diagn 1986, 6(2)83-87 10.1002/pd.1970060202 2422642
99. Gonen R Perez R David M Dar H Merksamer R Sharf M The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications Obstet Gynecol 1992, 80(1):83-86 1603504
100. Gordon YB Lewis JD Leighton M Kitau MJ Clarke PC Chard T Maternal serum alpha-fetoprotein levels as an index of fetal risk Am J Obstet Gynecol 1979, 133(4):422-424 86301
101. Haddow JE Kloza EM Smith DE Knight GJ Data from an alpha-fetoprotein pilot screening program in Maine Obstet Gynecol 1983, 62(5):556-60 6194484
102. Haddow JE Knight GJ Kloza EM Palomaki GE Alpha-fetoprotein, vaginal bleeding and pregnancy risk Br J Obstet Gynaecol 1986, 93(6):589-593 2425844
103. Haddow JE Palomaki GE Knight GJ Can low birth weight after elevated maternal serum alpha-fetoprotein be explained by maternal weight? Obstet Gynecol 1987, 70(1):26-28 2439965
104. Hamilton MP Abdalla HI Whitfield CR Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses Obstet Gynecol 1985, 65(4):465-470 2580253
105. Hayashi M Kohzu H [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases - the median value, pregnancy outcomes and clinical evaluation] Nippon Sanka Fujinka Gakkai Zasshi 1992, 44(10):1211-1218 1385554
106. Heikkila A Makkonen N Heinonen S Kirkinen P Elevated maternal serum hCG in the second trimester increases prematurity rate and need for neonatal intensive care in primiparous preeclamptic pregnancies Hypertens Pregnancy 2001, 20(1):99-106 12044318
107. Heinonen S Ryynanen M Kirkinen P The effects on fetal development of high alpha-fetoprotein and maternal smoking Am J Public Health 1999, 89(4):561-563 1508907 10191802
108. Hershkovitz R Erez O Sheiner E Landau D Mankuta D Mazor M Elevated maternal mid-trimester chorionic gonadotropin > or = 4 MoM is associated with fetal cerebral blood flow redistribution Acta Obstet Gynecol Scand 2003, 8(1)(2):22-27 10.1034/j.1600-0412.2003.820104.x
109. Kavak ZN Basgul A Elter K Uygur M Gokaslan H The efficacy of first-trimester PAPP-A and free betahCG levels for predicting adverse pregnancy outcome J Perinat Med 2006, 34(2):145-148 10.1515/JPM.2006.026 16519620
110. Kim SY Kim SK Lee JS Kim IK Lee K The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome Yonsei Med J 2000, 41(2):226-229 10817024
111. Kiran TS Bethel J Bhal PS Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome J Obstet Gynaecol 2005, 25(3):253-256 10.1080/01443610500060693 16147728
112. Krantz D Goetzl L Simpson JL Thom E Zachery J Hallahan TW Silver R Pergament E Platt LD Filkins K Johnson A Mahoney M Hogge WA Wilson RD Mohide P Hershey D Wapner R First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes Am J Obstet Gynecol 2004, 191(4):1452-1458 10.1016/j.ajog.2004.05.068 15507982
113. Kuo PL Lin CC Lin YH Guo HR Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels J Formos Med Assoc 2003, 102(5):319-325 12874670
114. Kwik M Morris J Association between first trimester maternal serum pregnancy associated plasma protein-A and adverse pregnancy outcome Aust N Z J Obstet Gynaecol 2003, 43(6):438-442 10.1046/ j.0004-8666.2003.00126.x 14712947
115. Legge M Duff GB Pike L Aickin DR Second trimester maternal serum alpha-fetoprotein as an indicator of fetal risk Aust N Z J Obstet Gynaecol 1985, 25(4):266-268 10.1111/j.1479-828X.1985.tb00741.x 2423067
116. Lepage N Chitayat D Kingdom J Huang T Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies Am J Obstet Gynecol 2003, 188(5):1354-1359 10.1067/ mob.2003.278 12748511
117. Lieppman RE Williams MA Cheng EY Resta R Zingheim R Hickok DE Luthy DA An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome Am J Obstet Gynecol 1993, 168(6 Pt 1):1852-1856 8317532
118. Markestad T Bergsjo P Aakvaag A Lie RT Jacobsen G Hoffman HJ Bakketeig LS Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol Acta Obstet Gynecol Scand Suppl 1997, 165:50-55 9219457
119. Milunsky A Nebiolo L Maternal serum triple analyte screening and adverse pregnancy outcome Fetal Diagn Ther 1996, 11(4):249-253 8823604
120. Miyakoshi K Tanaka M Gabionza D Ishimoto H Miyazaki T Yoshimura Y Prediction of smallness for gestational age by maternal serum human chorionic gonadotropin levels and by uterine artery Doppler study Fetal Diagn Ther 2001, 16(1):42-46 10.1159/000053879 11125251
121. Morssink LP Kornman LH Beekhuis JR De Wolf BT Mantingh A Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: Relation to fetal weight and preterm delivery Prenat Diagn 1995, 15(11):1041-1046 10.1002/pd.1970151109 8606883
122. Mwambingu FT Association between unaccountably high maternal alpha feto-protein and increased fetal risk Acta Obstet Gynecol Scand 1985, 64(3):275-276 2409736
123. Naylor CS Porto M Cohen B Garite TJ Pregnancy outcome in Hispanic patients with unexplained positive triple marker screening for Down syndrome J Matern Fetal Med 2001, 10(1):20-22 10.1080/714052710 11332414
124. Odibo AO Sehdev HM Stamilio DM Macones GA Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction Am J Perinatol 2006, 23(6):363-7 10.1055/s-2006-947724 16841275
125. Ogle R Jauniaux E Pahal GS Dell E Sheldrake A Rodeck C Serum screening for Down syndrome and adverse pregnancy outcomes: A case-controlled study Prenat Diagn 2000, 20(2):96-99 10.1002/ (SICI)1097-0223(200002)20:2<96::AID-PD766>3.0.CO;2-# 10694681
126. Pergament E Stein AK Fiddler M Cho NH Kupferminc MJ Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers Obstet Gynecol 1995, 86(2):255-258 10.1016/0029-7844(95)00108-4 7542379
127. Roop AP Boughman JA Blitzer MG Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome Maryland Medical Journal 1991, 40(9):779-784 1717806
128. Secher NJ Eriksen PS Hansen PK Lenstrup C Thisted J High maternal serum alpha-fetoprotein and low birthweight. A study concerning possible correlation between maternal weight, smoking, and serum alpha-fetoprotein and subsequent birthweight and gestational age Am J Perinatol 1985, 2(2):78-81 2420339
129. Smith GC Shah I Crossley JA Aitken DA Pell JP Nelson SM Cameron AD Connor MJ Dobbie R Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome Obstet Gynecol 2006, 107(1):161-6 16394054
130. Sritippayawan S Vachirasrisoontra C Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women J Med Assoc Thai 2005, 88(4):449-454 16146246
131. Summers AM Huang T Meier C Wyatt PR The implications of a false positive second-trimester serum screen for Down syndrome Obstet Gynecol 2003, 101(6):1301-1306 10.1016/S0029-7844(03)00235-7 12798540
132. Tanaka M Natori M Ishimoto Gohda N Kiyokawa K Yamauchi J Miyazaki T Kpbayashi T Nozawa S [Screening for adverse perinatal outcome by
133. Towner D Gandhi S El KD Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin Am J Obstet Gynecol 2006, 194(6):1676-81 10.1016/j.ajog.2006.03.011 16643816
134. Tul N Pusenjak S Osredkar J Spencer K Novak-Antolic Z Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A Prenat Diagn 2003, 23(12):990-996 10.1002/pd.735 14663836
135. Wald N Cuckle H Stirrat GM Bennett MJ Turnbull AC Maternal serum-alpha-fetoprotein and low birth-weight Lancet 1977, 2(8032):268-270 10.1016/S0140-6736(77)90953-9 69879
136. Wald NJ Cuckle HS Boreham J Turnbull AC Maternal serum alpha-fetoprotein and birth weight Br J Obstet Gynaecol 1980, 87(10):860-863 6158991
137. Weiner CP Grant SS Williamson RA Relationship between second trimester maternal serum alpha-fetoprotein and umbilical artery Doppler velocimetry and their association with preterm delivery Am J Perinatol 1991, 8(4):263-268 1720619
138. Wenstrom KD Sipes SL Williamson RA Grant SS Trawick DC Estle LC Prediction of pregnancy outcome with single versus serial maternal serum alpha-fetoprotein tests Am J Obstet Gynecol 1992, 167(6):1529-1533 1281964
139. Westergaard JG Teisner B Hau J Grudzinskas JG Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation Br J Obstet Gynaecol 1984, 91(12):1216-1223 6083800
140. Williams MA Hickok DE Zingheim RW Luthy DA Kimelman J Nyberg DA Mahon BS Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes Am J Obstet Gynecol 1992, 167(4 Pt 1):1032-1037 1384333
141. Zarzour SJ Gabert HA Diket AL St AM Miller JM Jr Abnormal maternal serum alpha fetoprotein and pregnancy outcome J Matern Fetal Med 1998, 7(6):304-307 10.1002/(SICI)1520-6661(199811/ 12)7:6<304::AID-MFM9>3.0.CO;2-4 9848697
142. Stroup DF Berlin JA Morton SC Olkin I Williamson GD Rennie D Moher D Beccker BJ Sipe TA Thacker SB Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 2000, 283(15):2008-2012 10.1001/jama.283.15.2008 10789670
143. Conde-Agudelo A Villar J Lindheimer M World health organization systematic review of screening tests for preeclampsia Obstet Gynecol 2004, 104(6):1367-1391 15572504
144. Cnossen JC Mol BW Post van der JAM Bossuyt PM ter Riet G World health organization systematic review of screening tests for pre-eclampsia Obstet Gynecol 2005, 105(5 Pt 1):1151-1152 15863566
145. Zwinderman AH Bossuyt PM We should not pool diagnostic likelihood ratios in systematic reviews Stat Med 2007
146. Reitsma JB Glas AS Rutjes AW Scholten RJ Bossuyt PM Zwinderman AH Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews J Clin Epidemiol 2005, 58(10):982-990 10.1016/j.jclinepi.2005.02.022 16168343
147. Whiting P Harbord R Kleijnen J No role for quality scores in systematic reviews of diagnostic accuracy studies BMC Med Res Methodol 2005, 5:19 1184082 15918898 10.1186/1471-2288-5-19
148. Brown MA Hague WM Higgins J Lowe S McCowan L Oats J Peek MJ Rowan JA Walters NJ The detection, investigation and management of hypertension in pregnancy: Full consensus statement Aust N Z J Obstet Gynaecol 2000, 40(2):139-155 10.1111/j.1479-828X.2000.tb01137.x 10925900
149. Shennan A Gupta M Halligan A Taylor DJ de Swiet M Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry Lancet 1996, 347(8995):139-142 10.1016/ S0140-6736(96)90338-4 8544546
150. Brown MA Reiter L Smith B Buddle ML Morris R Whitworth JA Measuring blood pressure in pregnant women: A comparison of direct and indirect methods Am J Obstet Gynecol 1994, 171(3):661-667 8092212
151. Clausson B Gardosi J Francis A Cnattingius S Perinatal outcome in SGA births defined by customised versus population based birthweight standards BJOG 2001, 108(8):830-834 10.1016/S0306-5456(00)00205-9 11510708
152. Scott K Usher R Fetal malnutrition: Its incidence, causes and effects Am J Obstet Gynecol 1986, 94(7):951-963
153. Deeks J Altman D Diagnostic tests: Likelihood ratios BMJ 2004, 329(7458):168-169 478236 15258077 10.1136/bmj.329.7458.168
154. Konchak PS Bernstein IM Capeless EL Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels Am J Obstet Gynecol 1995, 173(4):1115-1119 10.1016/0002-9378(95)91336-X 7485303